About this Video
Medullan hosted a workshop for Reuters: Pharma Clinical 2021 – With hybrid and decentralized clinical trials becoming the new normal, the use of sensor-based wearables, monitoring devices and clinical trial apps intended to regularly collect PRO and experience data are critically important to the success of the trial. Choosing, testing, modifying, and then validating devices and solutions for trials can be complex, yet it needs to be done quickly and effectively. The answers and validation are often, “outside the building” with the patients, caregivers, and investigators who will use these devices and tools. This was a highly engaging conversation about the real-world concerns and factors about preparing for success discussing:
- Standardizing and accelerating the process of choosing clinical trial devices
- Ensuring that devices provide endpoints that are both fit-for-purpose and exploratory
- Improving the consistency of wearables and devices used across the clinical research program
- Developing repeatable processes for future device selection
Watch it now
Complete this form to view the video.
About the Host
Todd Greenwood, Ph.D – Director, Client Solutions
Todd is a healthcare digital strategist who has more than a decade of experience driving and designing digital strategy for patient-centric programs designed to educate patients and caregivers, engage patients with their providers and improve adherence to therapy. Todd’s experience spans the digital space from Opportunity Development to Program Design to Outcomes and Insights.
Adriano Garcez, MBA
Director of Digital Health Strategy & Implementation, Medullan
Jincy Paulose, MD
Senior Medical Director, Novartis
Manager, ZS Associates